94 related articles for article (PubMed ID: 8967992)
1. Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.
Nguyen A; Kath JC; Hanson DC; Biggers MS; Canniff PC; Donovan CB; Mather RJ; Bruns MJ; Rauer H; Aiyar J; Lepple-Wienhues A; Gutman GA; Grissmer S; Cahalan MD; Chandy KG
Mol Pharmacol; 1996 Dec; 50(6):1672-9. PubMed ID: 8967992
[TBL] [Abstract][Full Text] [Related]
2. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.
Schmitz A; Sankaranarayanan A; Azam P; Schmidt-Lassen K; Homerick D; Hänsel W; Wulff H
Mol Pharmacol; 2005 Nov; 68(5):1254-70. PubMed ID: 16099841
[TBL] [Abstract][Full Text] [Related]
3. UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.
Hanson DC; Nguyen A; Mather RJ; Rauer H; Koch K; Burgess LE; Rizzi JP; Donovan CB; Bruns MJ; Canniff PC; Cunningham AC; Verdries KA; Mena E; Kath JC; Gutman GA; Cahalan MD; Grissmer S; Chandy KG
Br J Pharmacol; 1999 Apr; 126(8):1707-16. PubMed ID: 10372812
[TBL] [Abstract][Full Text] [Related]
4. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
[TBL] [Abstract][Full Text] [Related]
5. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
[TBL] [Abstract][Full Text] [Related]
6. Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.
Koo GC; Blake JT; Shah K; Staruch MJ; Dumont F; Wunderler D; Sanchez M; McManus OB; Sirotina-Meisher A; Fischer P; Boltz RC; Goetz MA; Baker R; Bao J; Kayser F; Rupprecht KM; Parsons WH; Tong XC; Ita IE; Pivnichny J; Vincent S; Cunningham P; Hora D; Feeney W; Kaczorowski G
Cell Immunol; 1999 Nov; 197(2):99-107. PubMed ID: 10607427
[TBL] [Abstract][Full Text] [Related]
7. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
8. WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
Hill RJ; Grant AM; Volberg W; Rapp L; Faltynek C; Miller D; Pagani K; Baizman E; Wang S; Guiles JW
Mol Pharmacol; 1995 Jul; 48(1):98-104. PubMed ID: 7542739
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
Angelova PR; Müller WS
Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
[TBL] [Abstract][Full Text] [Related]
10. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
12. NH2-terminal inactivation peptide binding to C-type-inactivated Kv channels.
Kurata HT; Wang Z; Fedida D
J Gen Physiol; 2004 May; 123(5):505-20. PubMed ID: 15078918
[TBL] [Abstract][Full Text] [Related]
13. Potassium channels as therapeutic targets for autoimmune disorders.
Wulff H; Beeton C; Chandy KG
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):640-7. PubMed ID: 14579513
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.
Koo GC; Blake JT; Talento A; Nguyen M; Lin S; Sirotina A; Shah K; Mulvany K; Hora D; Cunningham P; Wunderler DL; McManus OB; Slaughter R; Bugianesi R; Felix J; Garcia M; Williamson J; Kaczorowski G; Sigal NH; Springer MS; Feeney W
J Immunol; 1997 Jun; 158(11):5120-8. PubMed ID: 9164927
[TBL] [Abstract][Full Text] [Related]
15. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.
Baell JB; Gable RW; Harvey AJ; Toovey N; Herzog T; Hänsel W; Wulff H
J Med Chem; 2004 Apr; 47(9):2326-36. PubMed ID: 15084131
[TBL] [Abstract][Full Text] [Related]
16. Expression of voltage-gated K+ channels in human atrium.
Bertaso F; Sharpe CC; Hendry BM; James AF
Basic Res Cardiol; 2002 Nov; 97(6):424-33. PubMed ID: 12395204
[TBL] [Abstract][Full Text] [Related]
17. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the cloned delayed rectifier K+ channels, Kv1.5 and Kv3.1, by riluzole.
Ahn HS; Choi JS; Choi BH; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
Neuroscience; 2005; 133(4):1007-19. PubMed ID: 15964489
[TBL] [Abstract][Full Text] [Related]
19. Blockage of human T lymphocyte Kv1.3 channels by Pi1, a novel class of scorpion toxin.
Péter M; Hajdu P; Varga Z; Damjanovich S; Possani LD; Panyi G; Gáspár R
Biochem Biophys Res Commun; 2000 Nov; 278(1):34-7. PubMed ID: 11071851
[TBL] [Abstract][Full Text] [Related]
20. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
